|
NAA10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11489995013869E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12129999951804E-07 |
| Normal-vs-Stage2 |
3.11919999995691E-06 |
| Normal-vs-Stage3 |
5.90969999603175E-08 |
| Normal-vs-Stage4 |
7.83950000000644E-05 |
| Stage1-vs-Stage2 |
1.383030E-01 |
| Stage1-vs-Stage3 |
4.528000E-01 |
| Stage1-vs-Stage4 |
8.805600E-01 |
| Stage2-vs-Stage3 |
2.956400E-01 |
| Stage2-vs-Stage4 |
2.595200E-01 |
| Stage3-vs-Stage4 |
7.256600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32479999087809E-09 |
| Normal-vs-AfricanAmerican |
7.810200E-04 |
| Normal-vs-Asian |
1.57134999999586E-05 |
| Caucasian-vs-AfricanAmerican |
3.523400E-01 |
| Caucasian-vs-Asian |
5.614400E-01 |
| AfricanAmerican-vs-Asian |
2.625600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.49390000048611E-07 |
| Normal-vs-Female |
6.46769970913397E-10 |
| Male-vs-Female |
2.217800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.1970000030922E-08 |
| Normal-vs-Age(41-60Yrs) |
3.17339999944544E-07 |
| Normal-vs-Age(61-80Yrs) |
5.57120000133082E-08 |
| Normal-vs-Age(81-100Yrs) |
2.002400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.009800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.668800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.593000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.341400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.915600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.848800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.809200E-01 |
| Classical-VS-Follicular |
2.871800E-02 |
| Classical-VS-Other |
8.202400E-01 |
| Classical-VS-Normal |
1.06879999961507E-07 |
| Tall-VS-Follicular |
5.982100E-02 |
| Tall-VS-Other |
9.580200E-01 |
| Tall-VS-Normal |
2.182000E-03 |
| Follicular-VS-Other |
4.005200E-01 |
| Follicular-VS-Normal |
1.37840000524747E-08 |
| Other-VS-Normal |
4.304000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.78690412361493E-11 |
| Normal-vs-N1 |
1.28679999999992E-06 |
| N0-vs-N1 |
8.119000E-01 |
|
|
